Retraction
PIMREG, a Marker of Proliferation, Facilitates Aggressive Development of Cholangiocarcinoma Cells Partly Through Regulating Cell Cycle-Related Markers
Paper Information
Record ID:
53965
Author(s):
Publication Date:
December 24, 2020
Retraction Date:
June 06, 2024
(1.5 year years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
SAGE Publications
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1177/15330338241257889Additional Notes:
see also: https://pubpeer.com/publications/50E0D8E139A66DA2D559A354BF9D0C
Citations (9)
9
Total Citations0
Post-Retraction7
Pre-Retraction0
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing PIMREG, a Marker of Proliferation, Facilitates Agg...
Unknown Authors
Unknown Journal
Published: Unknown
FAM64A aggravates proliferation, invasion, lipid droplet formation, and chemoresistance in gastric cancer: A biomarker for aggressiveness and a gene therapy target
Wen-Jing Yun, Zhang Li, Ning Yang et al. (9 authors)
Drug Development Research
Open Access
Published: Aug 2023
4 citations
4 citations
300 days before retraction
A bioinformatics analysis of the clinicopathological and prognostic significance of <i>FAM64A</i> mRNA expression in gynecological cancers
Hua‐chuan Zheng, Dong-hui Ren, Congyu Zhang et al. (5 authors)
Journal of Obstetrics and Gynaecology
Open Access
Published: May 2023
6 citations
6 citations
378 days before retraction
PIMREG is a prognostic biomarker involved in immune microenvironment of clear cell renal cell carcinoma and associated with the transition from G1 phase to S phase
Huibao Yao, Feifei Lyu, Jian Ma et al. (7 authors)
Frontiers in Oncology
Open Access
Published: Jan 2023
2 citations
2 citations
497 days before retraction
Excessive activation of HOXB13/PIMREG axis promotes hepatocellular carcinoma progression and drug resistance
Cui Tang, Shixiong Qiu, Wenying Mou et al. (5 authors)
Biochemical and Biophysical Research Communications
Published: Jul 2022
10 citations
10 citations
689 days before retraction
Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients
Hua Zhu, Xinyao Hu, Feng Shi et al. (7 authors)
Frontiers in Immunology
Open Access
Published: Jul 2022
9 citations
9 citations
692 days before retraction
Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
Hua Zhu, Xinyao Hu, Yingze Ye et al. (7 authors)
Frontiers in Genetics
Open Access
Published: Sep 2021
22 citations
22 citations
996 days before retraction
Tumor-promoting function of PIMREG in glioma by activating the β-catenin pathway
Dekang Wang, Aili Hu, Hao Peng et al. (5 authors)
3 Biotech
Open Access
Published: Jul 2021
3 citations
3 citations
1049 days before retraction
Quick Stats
Total Citations:
9
Years Since Retraction:
1.5 year
Open Access:
Yes
Last Checked:
Jul 24, 2025